Investors are set to see the market debut of Manipal Health Enterprises IPO on August 5, with shares scheduled to list on the BSE and NSE mainboard platforms. However, muted investor sentiment and weak grey market trends suggest the stock may witness a subdued opening.
The IPO is currently trading at a discount of around Rs 5-6 in the grey market, pointing towards an estimated listing price of nearly Rs 584 per share, compared with the upper end of the IPO price band of Rs 590. While the grey market premium (GMP) is often tracked as an indicator of market mood, it remains an unofficial and unregulated market signal and does not guarantee listing-day performance.